The interference of botanicals and nutraceuticals with the effects of antithrombotic agents: How should the available evidence be weighed?

Thrombosis Research

Volumn 117, Issue 1-2, 2005, Pages 19-24

  De Smet, Peter A G M ^a,b  

^a Scientific Institute Dutch Pharmacists   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTICOAGULANT AGENT; FISH OIL; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; HYPERICUM PERFORATUM EXTRACT; NONSTEROID ANTIINFLAMMATORY AGENT; NUTRACEUTICAL; PHYTOMENADIONE; UBIDECARENONE; WARFARIN;

ANTICOAGULATION; BLEEDING; BLOOD CLOT LYSIS; CHEMICAL INTERACTION; CLINICAL TRIAL; CONFERENCE PAPER; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG HYPERSENSITIVITY; DRUG SAFETY; HEALTH CARE; HEALTH PROGRAM; HERB DRUG INTERACTION; HUMAN; MEDICAL INFORMATION; MEDICAL PRACTICE; OUTCOMES RESEARCH; PHARMACOGENETICS; PREVALENCE; PRIORITY JOURNAL; PROTHROMBIN TIME; QUALITATIVE ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; THROMBOSIS; VITAMIN SUPPLEMENTATION;

CLINICAL TRIALS; DIETARY SUPPLEMENTS; EVIDENCE-BASED MEDICINE; FIBRINOLYTIC AGENTS; FOOD-DRUG INTERACTIONS; HEALTH FOOD; HUMANS; PLANTS, MEDICINAL; RISK ASSESSMENT; RISK FACTORS;

EID: 27744561161     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2005.09.001     Document Type: Conference Paper

References (42)

1. H. Wassén "Ulluchu" in Moche iconography and blood ceremonies: the search for identification Göteborgs etnografiska museum annals 1985/86 1987 59 85
2. R. Larco Hoyle Los mochicas 2001 Museo Arqueológico Rafael Larco Herrera Lima
3. X. Scheldeman, J.P. Romero-Motochi, V. Van Damme, V. Heyens, and P. Van Damme Potential of highland papayas (Vasconcellea spp.) in southern Ecuador 2001 Available at: http://www.br.fgov.be/BIODIV/BBB/poster.html (accessed Jan 02, 2005)
4. J. Concato, N. Shah, and R.I. Horwitz Randomized, controlled trials, observational studies, and the hierarchy of research designs N Engl J Med 342 2000 1887 1892
5. X. Jiang, K.M. Williams, W.S. Liauw, A.J. Ammit, B.D. Roufogalis, and C.C. Duke Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects Br J Clin Pharmacol 57 2004 592 599
6. C.S. Yuan, G. Wei, L. Dey, T. Karrison, L. Nahlik, and S. Maleckar Brief communication: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled Trial Ann Intern Med 141 2004 23 27
7. J. Engelsen, J.D. Nielsen, and K. Winther Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in stable, long-term warfarin treated outpatients. A randomised, double blind, placebo-crossover trial Thromb Haemost 87 2002 1075 1076
8. N.K. Bender, M.A. Kraynak, E. Chiquette, W.D. Linn, G.M. Clark, and H.I. Bussey Effects of marine fish oils on the anticoagulation status of patients receiving chronic warfarin therapy J Thromb Thrombolysis 5 1998 257 261
9. J.M. Kim, and R.H. White Effect of vitamin E on the anticoagulant response to warfarin Am J Cardiol 77 1996 545 546
10. M.F. Rosado Thrombosis of a prosthetic aortic valve disclosing a hazardous interaction between warfarin and a commercial ginseng product Cardiology 99 2003 111
11. M. Rosenblatt, and J. Mindel Spontaneous hyphema associated with ingestion of Ginkgo biloba extract N Engl J Med 336 1997 1108
12. M.K. Matthews Jr. Association of Ginkgo biloba with intracerebral hemorrhage Neurology 50 1998 1933 1934
13. D. Hauser, T. Gayowski, and N. Singh Bleeding complications precipitated by unrecognized Gingko biloba use after liver transplantation Transpl Int 15 2002 377 379
14. O. Spigset Reduced effect of warfarin caused by ubidecarenone Lancet 344 1994 1372 1373
15. C. Landbo, and T.P. Almdal Interaktion mellem warfarin og coenzym Q10 Ugeskr Laeger 160 1998 3226 3227
16. L.M. Porterfield Why did the response to warfarin change? RN 63 2000 107
17. M.S. Buckley, A.D. Goff, and W.E. Knapp Fish oil interaction with warfarin Ann Pharmacother 38 2004 50 52
18. J.J. Corrigan Jr., and F.I. Marcus Coagulopathy associated with vitamin E ingestion JAMA 230 1974 1300 1301
19. B.H. Stricker, and B.M. Psaty Detection, verification, and quantification of adverse drug reactions BMJ 329 2004 44 47
20. J.P. Vandenbroucke When are observational studies as credible as randomised trials? Lancet 363 2004 1728 1731
21. D. Kurnik, A. Lubetsky, R. Loebstein, S. Almog, and H. Halkin Multivitamin supplements may affect warfarin anticoagulation in susceptible patients Ann Pharmacother 37 2003 1603 1606
22. D. Kurnik, R. Loebstein, H. Rabinovitz, N. Austerweil, H. Halkin, and S. Almog Over-the-counter vitamin K1-containing multivitamin supplements disrupt warfarin anticoagulation in vitamin K1-depleted patients. A prospective, controlled trial Thromb Haemost 92 2004 1018 1024
23. S. Schulman Oral anticoagulation E. Beutler M.A. Lichtman B.S. Coller T.J. Kipps U. Seligsohn William hematology 6th edition 2001 McGraw-Hill New York 1777 1792
24. P.A.G.M. De Smet Health risks of herbal remedies: an update Clin Pharmacol Ther 76 2004 1 17
25. P.A.G.M. De Smet Toxicological outlook on the quality assurance of herbal remedies P.A.G.M. De Smet K. Keller R. Hänsel R.F. Chandler Adverse Effects of Herbal Drugs vol. 1 1992 Springer-Verlag Berlin 1 72
26. W.A. Norcross, T.G. Ganiats, L.P. Ralph, R.G. Seidel, and T.S. Ikeda Accidental poisoning by warfarin-contaminated herbal tea West J Med 159 1993 80 82
27. G.G. Duncan Re: does PC-SPES interact with warfarin? J Urol 169 2003 294 295
28. L.E. Visser, R.H.N. Van Schaik, M. Van Vliet, P.H. Trienekens, P.A.G.M. De Smet, and A.G. Vulto Allelic variants of cytochrome P450 2C9 modify the interaction between nonasteroidal anti-inflammatory drugs and coumarin anticoagulants Clin Pharmacol Ther 77 2005 479 485
29. R. Suvarna, M. Pirmohamed, and L. Henderson Possible interaction between warfarin and cranberry juice BMJ 327 2003 1454
30. M. Makris, and R.M. Maclean Interaction between warfarin and cranberry juice. Premature conclusion? 2004 Available at: http://bmj.bmjjournals.com/cgi/ eletters/327/7429/1454 (accessed Jan 02 2005)
31. D.H. Bevan Cranberry sauce 2004 Available at: http://bmj.bmjjournals.com/ cgi/eletters/327/7429/1454 (accessed Jan 02 2005)
32. P.A.G.M. De Smet An introduction to herbal pharmacovigilance P.A.G.M. De Smet K. Keller R. Hänsel R.F. Chandler Adverse Effects of Herbal Drugs vol. 3 1997 Springer-Verlag Berlin 1 13
33. Anonymous The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC cancer prevention study group Ann Epidemiol 4 1994 1 10
34. K.E. Liede, J.K. Haukka, L.M. Saxen, and O.P. Heinonen Increased tendency towards gingival bleeding caused by joint effect of alpha-tocopherol supplementation and acetylsalicylic acid Ann Med 30 1998 542 546
35. P.M. Kuijer, B.A. Hutten, M.H. Prins, and H.R. Buller Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism Arch Intern Med 159 1999 457 460
36. R.J. Beyth, L. Quinn, and C.S. Landefeld A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial Ann Intern Med 133 2000 687 695
37. P.S. Wells, M.A. Forgie, M. Simms, A. Greene, D. Touchie, and G. Lewis The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism Arch Intern Med 163 2003 917 920
38. M.H. Eckman, J.K. Erban, S.K. Singh, and G.S. Kao Screening for the risk for bleeding or thrombosis Ann Intern Med 138 2003 W15 W24
39. T. Schalekamp, M. Oosterhof, E. van Meegen, F.J. Der Meer, J. Conemans, and M. Hermans Effects of cytochrome P450 2C9 polymorphisms on phenprocoumon anticoagulation status Clin Pharmacol Ther 76 2004 409 417
40. A.K. Wittkowsky, and E.B. Devine Frequency and causes of overanticoagulation and underanticoagulation in patients treated with warfarin Pharmacotherapy 24 2004 1311 1316
41. L.E. Visser, P.H. Trienekens, P.A.G.M. De Smet, A.G. Vulto, A. Hofman, and C.M. Van Duijn Patients with an APOE E4 allele require lower doses of coumarin anticoagulants Pharmacogenetics 15 2005 69 74
42. A.M. Holbrook, J.A. Pereira, R. Labiris, H. McDonald, J.D. Douketis, and M. Crowther Systematic overview of warfarin and its drug and food interactions Arch Intern Med 165 2005 1095 1096